BF
TIL icon

BOK Financial’s Instil Bio TIL Stock Holding History

BOK Financial’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-454
Closed -$3.74K – 1214
2026
Q1 		$3.74K Buy
+454
New +$3.68K ﹤0.01% 993
2025
Q4 		– Sell
-454
Closed -$8.11K – 1122
2025
Q3 		$8.11K Hold
454
– – ﹤0.01% 1034
2025
Q2 		$9.46K Hold
454
– – ﹤0.01% 968
2025
Q1 		$7.88K Hold
454
– – ﹤0.01% 999
2024
Q4 		$9.01K Buy
454
+100
+28% +$3.05K ﹤0.01% 982
2024
Q3 		$18.5K Buy
+354
New +$8.34K ﹤0.01% 931

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

BOK Financial's TIL Position: Q2 2026 in Review

BOK Financial sold out of Instil Bio (TIL) in Q2 2026, closing a stake of 454 shares — an estimated $3.74K sold.

BOK Financial first reported a position in TIL in Q3 2024 and held it in 6 quarters. The position peaked at $18.5K in Q3 2024. 26 funds tracked by Wall St. Rank hold TIL as of Q2 2026.

  • BOK Financial reported no remaining Instil Bio position as of Q2 2026 after selling out during the quarter.
  • BOK Financial sold 454 Instil Bio shares in Q2 2026, an estimated $3.74K.
  • BOK Financial first reported a position in Instil Bio in Q3 2024 and held it in 6 quarters.
  • BOK Financial's Instil Bio position peaked at $18.5K in Q3 2024.
  • 26 funds tracked by Wall St. Rank held Instil Bio as of Q2 2026.

Based on BOK Financial's 13F filing for Q2 2026, filed 10 Aug 2026.